Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greater China Corporation (GCHC) was a diversified holding company that focused on the healthcare and telecommunications sectors in the Greater China region. The company's healthcare division, primarily operated through its subsidiary Asia Health Care, was involved in the management and development of medical facilities, including the Hainan Sanya Traditional Chinese Medicine Hospital. Its business strategy aimed to modernize traditional Chinese medicine and expand access to Western-style healthcare services in China. Although it was once an active participant in the regional healthcare market and publicly traded on the OTC market, the company has since become inactive and is currently classified as a shell entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greater China Corporation.